Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan · Delayed Price · Currency is TWD 46.95
+1.35 (2.96%)
Sep 8, 2026, 1:30 PM CST
Oneness Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21,865 | 26,600 | 41,683 | 88,028 | 95,221 | 109,494 | |
Market Cap Growth | -40.00% | -36.18% | -52.65% | -7.55% | -13.04% | 21.98% |
Enterprise Value | 16,931 | 21,578 | 35,382 | 80,760 | 87,283 | 102,525 |
Last Close Price | 45.60 | 55.60 | 87.30 | 185.24 | 205.42 | 240.56 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 359.53 | - | - | - | 264.52 | - |
Forward PE | - | 160.48 | 160.48 | 160.48 | - | - |
PS Ratio | 142.18 | 206.01 | 353.46 | 1014.35 | 89.36 | 1664.92 |
PB Ratio | 2.10 | 2.54 | 3.26 | 6.07 | 6.40 | 7.77 |
P/TBV Ratio | 2.34 | 2.85 | 3.75 | 7.17 | 7.61 | 9.49 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 110.10 | 167.12 | 300.04 | 930.60 | 81.91 | 1558.95 |
EV/EBITDA Ratio | - | - | - | - | 377.48 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 |
Debt / EBITDA Ratio | - | - | - | - | 1.05 | - |
Net Debt / Equity Ratio | -0.49 | -0.52 | -0.52 | -0.51 | -0.52 | -0.53 |
Net Debt / EBITDA Ratio | 10.00 | 10.56 | 9.71 | 10.89 | -33.66 | 10.56 |
Net Debt / FCF Ratio | 26.73 | 11.31 | 16.73 | 14.33 | 8.04 | 19.58 |
Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.07 | 0.00 |
Inventory Turnover | 0.89 | 0.80 | 0.46 | 0.46 | 2.30 | 0.32 |
Quick Ratio | 36.36 | 11.44 | 38.90 | 36.45 | 38.73 | 50.46 |
Current Ratio | 37.31 | 11.81 | 39.87 | 37.23 | 39.47 | 51.21 |
Return on Equity (ROE) | 0.62% | -9.10% | -8.45% | -9.00% | 2.43% | -2.96% |
Return on Assets (ROA) | -4.27% | -3.95% | -4.68% | -4.43% | -0.96% | -3.53% |
Return on Invested Capital (ROIC) | -12.48% | -14.32% | -16.28% | -15.39% | -2.75% | -14.26% |
Return on Capital Employed (ROCE) | -7.10% | -7.20% | -8.10% | -7.20% | -1.60% | -5.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.28% | -3.93% | -2.79% | -1.49% | 0.38% | -0.37% |
FCF Yield | -0.87% | -1.81% | -0.95% | -0.58% | -1.02% | -0.35% |
Dividend Yield | - | - | - | - | 0.04% | - |
Buyback Yield / Dilution | -0.30% | -0.25% | -0.97% | -0.40% | -3.58% | -6.82% |
Total Shareholder Return | -0.30% | -0.25% | -0.97% | -0.40% | -3.54% | -6.82% |